mjn-SERAS is a system to help people with epilepsy.
mjn-SERAS is a medical device that sends a warning signal when the risk of epileptic seizures is high, to the affected person and his or her trusted contacts.
1
RECORDS BRAIN ACTIVITY
mjn-SERAS records the electrical activity of the brain in real time and stores the information on dedicated servers.
2
3D PRINTED HEADSET
El sensor de mjn-SERAS is customized by taking a mold of the user’s ear canal prior to fabrication using 3D printing techniques.
3
ARTIFICIAL INTELLIGENCE
Bluetooth® headset with brain electrical activity sensor. Connection to Android phone through the app of mjn-SERAS. Allows you to choose the contacts that receive all the user’s alerts.
mjn-SERAS is a medical device with CE marking ccording to the European Medical Device Regulation – Regulation (EU) 2017/745 – and Royal Decree 192/2023.
Contraindications: Do not use the device in case of an infection in the ear canal or in case of skin lesions in the vicinity of the product. mjn-SERAS or SERAS_Epilepsy is a device designed and indicated for patients diagnosed with epilepsy who meet specific requirements in relation to the form of manifestation of epilepsy in their own case. For users who do not meet these requirements,, the feasibility of the use of the device may be analyzed by the technical team of MJN NEUROSERVEIS, establishing in such case, the necessary additional considerations.
Considerations: This medical device works with an APP on iOS or Android phones. The tested results in Hospital are 96% sensitivity and 94% specificity. CPSP20103CAT.
Artificial intelligence app
mjn-SERAS analyzes the electrical activity of a person's brain by means of artificial intelligence algorithms to determine the risk of epileptic seizures.
- mjn-SERAS records the brain’s electrical activity in real time and stores the information on specific servers.
- The headset and the app record seizure alarms in real time and store the information.
- It also determines in real time the performance of the epilepsy seizure risk assessment algorithm.
mjn-SERAS is a medical device with CE marking ccording to the European Medical Device Regulation – Regulation (EU) 2017/745 – and Royal Decree 192/2023.
Contraindications: Do not use the device in case of an infection in the ear canal or in case of skin lesions in the vicinity of the product. mjn-SERAS or SERAS_Epilepsy is a device designed and indicated for patients diagnosed with epilepsy who meet specific requirements in relation to the form of manifestation of epilepsy in their own case. For users who do not meet these requirements,, the feasibility of the use of the device may be analyzed by the technical team of MJN NEUROSERVEIS, establishing in such case, the necessary additional considerations.
Considerations: This medical device works with an APP on iOS or Android phones. The tested results in Hospital are 96% sensitivity and 94% specificity. CPSP20103CAT.
NOW AVAILABLE FOR IOS & ANDROID PHONES!
mjn-SERAS is a medical device with CE marking ccording to the European Medical Device Regulation – Regulation (EU) 2017/745 – and Royal Decree 192/2023.
Contraindications: Do not use the device in case of an infection in the ear canal or in case of skin lesions in the vicinity of the product. mjn-SERAS or SERAS_Epilepsy is a device designed and indicated for patients diagnosed with epilepsy who meet specific requirements in relation to the form of manifestation of epilepsy in their own case. For users who do not meet these requirements,, the feasibility of the use of the device may be analyzed by the technical team of MJN NEUROSERVEIS, establishing in such case, the necessary additional considerations.
Considerations: This medical device works with an APP on iOS or Android phones. The tested results in Hospital are 96% sensitivity and 94% specificity. CPSP20103CAT.
Small and discreet
With a great potential inside
- mjn-SERAS is a new medical device from mjn-neuro.
- It has been developed during more than 4 years of technical evolution.
- The artificial intelligence algorithm that continuously assesses the risk of epileptic seizures runs in real time in the mjn-SERAS application on the user’s cell phone.
Small and discreet
With a great potential inside
- mjn-SERAS is a new medical device from mjn-neuro.
- It has been developed during more than 4 years of technical evolution.
- The artificial intelligence algorithm that continuously assesses the risk of epileptic seizures runs in real time in the mjn-SERAS application on the user’s cell phone.
mjn-SERAS is a medical device with CE marking in accordance with the European Directive 93/42/EEC and the Royal Decree RD. 1591/2009.
Contraindications: Do not use the product if you have an infection in the ear canal or if you have a skin lesion in the vicinity of the product’s area of influence.
Considerations: This medical device works with an APP only on Android phones. The tested results are 96% sensitivity and 94% specificity.
CPSP20103CAT.
mjn-SERAS GENERATES A NOTICE TO THE USER WHEN THE RISK OF EPILEPSY CRISIS IS ELEVATED
It is a support system for people with epilepsy that helps manage epileptic seizures.
mjn-SERAS MONITORING BRAIN ACTIVITY
Sensors in the mjn-SERAS headset synchronize real-time brain activity data in the app.
COMFORTABLE, LIGHTWEIGHT AND CUSTOM-DESIGNED
Hearing aid experts design the earpiece using 3D printing techniques to ensure comfort.
REAL-TIME RECORDING OF EPILEPSY SEIZURE ALARMS
mjn-SERAS stores all the information in specific servers.
mjn-SERAS ALLOWS TO TAKE SAFETY MEASURES BEFORE SEIZURE OCCURS
Features
mjn-SERAS
- Bluetooth® headset with brain activity sensor.
- Custom sensor printed in 3D.
- Connection to smartphone through the mjn-SERAS app.
- Allows you to choose the contacts that receive all user alerts.
- Performs statistics of epilepsy seizures.
- It has technical assistance and software updates.
mjn-SERAS is a medical device with CE marking ccording to the European Medical Device Regulation – Regulation (EU) 2017/745 – and Royal Decree 192/2023.
Contraindications: Do not use the device in case of an infection in the ear canal or in case of skin lesions in the vicinity of the product. mjn-SERAS or SERAS_Epilepsy is a device designed and indicated for patients diagnosed with epilepsy who meet specific requirements in relation to the form of manifestation of epilepsy in their own case. For users who do not meet these requirements,, the feasibility of the use of the device may be analyzed by the technical team of MJN NEUROSERVEIS, establishing in such case, the necessary additional considerations.
Considerations: This medical device works with an APP on iOS or Android phones. The tested results in Hospital are 96% sensitivity and 94% specificity. CPSP20103CAT.
Contact us
Be the first to find out
Would you like to be informed about the latest news related to the project?
